Physician

Angelo Mastrosimone, MD

According to 2025 Medicare claims, Angelo Mastrosimone, MD (NPI: 1801998018) practices allergy/immunology in the Trenton-Princeton, NJ market, with the plurality of this provider's patient population coming from Mercer, NJ. Mastrosimone uses personal NPI as billing NPI and primary practice location at 08648-2526.

Mastrosimone's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 16 traditional Medicare patients, billed 320 HCPCS/CPT codes, and received $4,067 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 323 prescription claims across 48 beneficiaries totaling $51,738 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). Open Payments data shows 2 records totaling $33. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $23,180 to $4,067. Concurrently, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$12K$24K2015 Medicare payment: $23,180 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $24,055 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $17,046 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $16,731 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $12,665 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $5,148 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,535 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,043 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $4,051 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $4,067 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015802,087$23,180
2016762,337$24,055
2017511,561$17,046
2018511,592$16,731
2019351,072$12,665
202021499$5,148
202117322$3,535
202215302$3,043
202314354$4,051
202416320$4,067

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$31K$63K2015 Drug cost: $58,668 (USD; Tot_Drug_Cst)2016 Drug cost: $51,400 (USD; Tot_Drug_Cst)2017 Drug cost: $49,776 (USD; Tot_Drug_Cst)2018 Drug cost: $45,653 (USD; Tot_Drug_Cst)2019 Drug cost: $53,756 (USD; Tot_Drug_Cst)2020 Drug cost: $62,610 (USD; Tot_Drug_Cst)2021 Drug cost: $51,235 (USD; Tot_Drug_Cst)2022 Drug cost: $50,368 (USD; Tot_Drug_Cst)2023 Drug cost: $51,521 (USD; Tot_Drug_Cst)2024 Drug cost: $51,738 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201584420$58,668
201678456$51,400
201773359$49,776
201865348$45,653
201962325$53,756
202050390$62,610
202147286$51,235
202252272$50,368
202352323$51,521
202448323$51,738

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more1216$94

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Trelegy ElliptaFluticasone/Umeclidin/Vilanter481,680$35,618
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr12360$5,527
Azelastine-FluticasoneAzelastine/Fluticasone161,020$4,424
Azelastine HclAzelastine Hcl391,930$1,450
Fluticasone PropionateFluticasone Propionate221,236$363

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$33GlaxoSmithKline, LLC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Angelo Mastrosimone, MD?

Tedicare shows public-source Medicare data for Angelo Mastrosimone, MD (NPI 1801998018), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Angelo Mastrosimone, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Angelo Mastrosimone, MD?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does Angelo Mastrosimone, MD have Open Payments data?

Angelo Mastrosimone, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.